In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of Tenaya Therapeutics Inc (NASDAQ: TNYA) was $0.59 for the day, down -1.55% from the previous closing price of $0.60. In other words, the price has decreased by -$1.55 from its previous closing price. On the day, 1.95 million shares were traded.
Ratios:
Our analysis of TNYA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.68 and its Current Ratio is at 6.68. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.08.
On November 30, 2023, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $7.
On June 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.H.C. Wainwright initiated its Buy rating on June 15, 2022, with a $25 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 16 ’25 when Higa Tomohiro sold 1,390 shares for $0.44 per share. The transaction valued at 615 led to the insider holds 98,300 shares of the business.
Tingley Whittemore sold 2,937 shares of TNYA for $1,300 on May 16 ’25. The Chief Medical Officer now owns 171,856 shares after completing the transaction at $0.44 per share. On May 16 ’25, another insider, Ali Faraz, who serves as the Chief Executive Officer of the company, sold 3,189 shares for $0.44 each. As a result, the insider received 1,412 and left with 317,325 shares of the company.
Stock Price History:
Over the past 52 weeks, TNYA has reached a high of $4.06, while it has fallen to a 52-week low of $0.36. The 50-Day Moving Average of the stock is 21.86%, while the 200-Day Moving Average is calculated to be -58.02%.
Shares Statistics:
A total of 162.66M shares are outstanding, with a floating share count of 134.18M. Insiders hold about 17.51% of the company’s shares, while institutions hold 28.52% stake in the company.
Earnings Estimates
At present, 7.0 analysts are actively evaluating the performance of Tenaya Therapeutics Inc (TNYA) in the stock market.The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.11 and low estimates of -$0.28.
Analysts are recommending an EPS of between -$0.58 and -$1.07 for the fiscal current year, implying an average EPS of -$0.79. EPS for the following year is -$0.63, with 5.0 analysts recommending between -$0.53 and -$0.67.
